5 completed, 3 terminated, 2 recruiting, 2 unknown. 12 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 12 | Completed 5, Terminated 3, Recruiting 2, Unknown 2 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Postoperative Hemorrhage: new trials by email Literature Review of Postoperative Hemorrhage trials Research Report on Postoperative Hemorrhage
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy Use of topical estradiol, No intervention - Postoperative Bleeding, Gender Dysphoria | Phase 3 | Recruiting | Women and Infants Hospital of Rhode Island | 48 | 2025-05-01 | 2025-05-13 |
| Effect of Early Administration of TXA in Adult Hip Fractures Tranexamic acid - Postoperative Blood Loss | Phase 2 / Phase 3 | Recruiting | Ascension Health | 170 | 2021-09-01 | 2021-09-16 |
| Preoperative Hexakapron Reduces Bleeding in Bariatric Surgery tranexamic acid, Placebo - Intra-Operative Injury - Other, Post Operative Hemorrhage | Phase 3 | Terminated | Sheba Medical Center | 152 | 2017-09-01 | 2023-04-19 |
| HepciFer Study: Hepcidin Overexpression After Hepatectomy : Does Iron Supplementation Make Sense ? IV iron, IV placebo - Anemia, Postoperative Blood Loss | Phase 3 | Completed | University Hospital, Geneva | 50 | 2015-10-01 | 2017-05-05 |
| Intravenous Tranexamic Acid Versus Pericervical Tourniquet To Decrease Blood Loss In Trans-Abdominal Myomectomy Tranexamic Acid, Pericervical Tourniquet - Post Operative Hemorrhage | Phase 3 | Unknown | Ain Shams Maternity Hospital | 70 | 2015-08-01 | 2016-04-12 |
| Non-inferiority Trial of Oral Tranexamic Acid vs. Intravenous Tranexamic Acid in Joint Replacement Surgery Tranexamic Acid (Oral), Tranexamic Acid (Intravenous) - Osteoarthritis, Blood Loss, Surgical | Phase 3 | Unknown | The New England Baptist Hospital | 118 | 2015-04-01 | 2016-03-22 |
| Tranexamic Acid in Reverse Total Shoulder Arthroplasty Tranexamic Acid, Placebo - Shoulder Joint Disease, Complications; Arthroplasty | Phase 2 / Phase 3 | Completed | Corewell Health East | 116 | 2013-09-01 | 2017-06-19 |
| Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery Fibrinogen Concentrate (Human) (FCH), Placebo - Surgical Blood Loss, Postoperative Blood Loss | Phase 3 | Completed | CSL Behring | 152 | 2012-01-01 | 2014-09-18 |
| Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery Trasylol (Aprotinin, BAYA0128), Placebo - Blood Loss, Surgical, Postoperative Hemorrhage | Phase 3 | Terminated | Bayer | 54 | 2006-02-27 | 2019-06-04 |
| Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total Cystectomy Trasylol (Aprotinin, BAYA0128), Placebo - Blood Loss, Surgical, Postoperative Hemorrhage | Phase 3 | Terminated | Bayer | 57 | 2005-12-01 | 2014-12-17 |
| Hetastarch and Bleeding Complications After Off-Pump Coronary Bypass Surgery hetastarch - Postoperative Hemorrhage | Phase 3 | Completed | Kaiser Permanente | 330 | 2004-09-01 | 2006-05-22 |
| Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass Heparin, HH or high heparin, heparin concentration HC - Postoperative Hemorrhage | Phase 3 | Completed | Mayo Clinic | 270 | 2001-06-01 | 2009-10-15 |
Blood Loss, Surgical (5) · Hemorrhage (2) · Anemia (1) · Arthritis (1) · Gender Dysphoria (1) · Intraoperative Complications (1) · Joint Diseases (1) · Musculoskeletal Diseases (1) · Obesity, Morbid (1) · Osteoarthritis (1) · Pathologic Processes (1) · Postoperative Complications (1)
Pathological Conditions, Signs and Symptoms (12) · Pathologic Processes (11) · Postoperative Complications (11) · Hemorrhage (10) · Intraoperative Complications (4) · Arthritis (1) · Body Weight (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Joint Diseases (1) · Mental Disorders (1) · Musculoskeletal Diseases (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Obesity (1)
Tranexamic Acid (5) · Aprotinin (2) · Antifibrinolytic Agents (1) · Fibrinogen (1) · Heparin (1) · Hydroxyethyl Starch Derivatives (1) · Saline Solution (1) · ferric carboxymaltose (1) · ferryl iron (1)
Bayer (2) · Ain Shams Maternity Hospital (1) · Ascension Health (1) · CSL Behring (1) · Corewell Health East (1) · Kaiser Permanente (1) · Mayo Clinic (1) · Sheba Medical Center (1) · The New England Baptist Hospital (1) · University Hospital, Geneva (1) · Women and Infants Hospital of Rhode Island (1)
United States (7) · Germany (3) · Canada (2) · United Kingdom (2) · Austria (1) · Belgium (1) · Brazil (1) · Czechia (1) · Denmark (1) · Egypt (1) · Finland (1) · France (1) · Israel (1) · Italy (1) · Japan (1)
Ahmad M BahaaEldin, MD (1) · Eduardo Schiffer, MD (1) · Kenneth Bauer, MD (1) · Kevin Baker, PhD (1) · Marketa Hecht, MD (1) · Michael J Wiater, M.D. (1) · Niels Rahe-Meyer, MD, PhD (1) · William Oliver, MD (1)
PMID 19698859, PMID 22777369, PMID 24947034, PMID 27317703, PMID 30252728, PMID 30462259, PMID 35123055, PMID 36089115, PMID 37553914, PMID 37581673, PMID 38823625
2005 (2)